Comments
Loading...
Stoke Therapeutics (STOK) Forecast
NewsEarningsStoke Therapeutics (STOK) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestStoke Therapeutics (NASDAQ:STOK) Stock Quotes, Forecast and News Summary
Stoke Therapeutics Stock (NASDAQ: STOK) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Stoke Therapeutics (STOK) stock?
You can purchase shares of Stoke Therapeutics (NASDAQ:STOK) through any online brokerage.
Who are Stoke Therapeutics (STOK) competitors?
Other companies in Stoke Therapeutics’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Immunome (NASDAQ:IMNM), Humacyte (NASDAQ:HUMA), Altimmune (NASDAQ:ALT) and Pharming (NASDAQ:PHAR).
What is the forecast, or price target, for Stoke Therapeutics (STOK) stock?
Stoke Therapeutics has a consensus price target of $24.00.
What is the current price for Stoke Therapeutics (STOK)?
The stock price for Stoke Therapeutics (NASDAQ: STOK) is $11.68 last updated December 20, 2024 at 4:00 PM EST.
Does Stoke Therapeutics (STOK) pay a dividend?
There are no upcoming dividends for Stoke Therapeutics.
When is Stoke Therapeutics (NASDAQ:STOK) reporting earnings?
Stoke Therapeutics’s Q3 earnings are confirmed for Tuesday, November 5, 2024.
Is Stoke Therapeutics (STOK) going to split?
There is no upcoming split for Stoke Therapeutics.
What sector and industry does Stoke Therapeutics (STOK) operate in?
Stoke Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.